Eight organisations established a new international consortium across Africa and Europe to strengthen access to tuberculosis (TB) preventive treatment. How? Through innovative testing, digital health solutions, and community-based care. The consortium TEST4TPT, collaborates to address one of the most persistent challenges in TB prevention to date: early identification of people exposed to TB and connecting them to preventive care.

For those preparing to pursue a career in Medicine, direct exposure to clinical realities can profoundly transform the way they understand the profession. This was precisely the experience lived by a group of students from the University of Navarra, Spain, during an internship at the Manhiça Health Research Centre (CISM) and the Manhiça District Hospital (HDM). There, they had the opportunity to gain first-hand experience of health research, clinical practice and the challeng

Scheduled for late November, the Forum is expected to bring together health institutions, communication professionals and journalists, researchers, policymakers, civil society organisations, development partners, academia and the private sector, in a space for sharing experiences, reflecting on challenges and identifying solutions for more effective, accessible and people-centred health communication.

The project will evaluate a strategy combining home-based tuberculosis skin testing using SIILTIBCY, the involvement of Community Health Workers (Agentes Polivalentes Elementares – APEs), and the use of AI to support the interpretation of test results.

The results indicate that women exposed to ivermectin around the time of conception did not have a significantly increased risk of miscarriage, stillbirth or major congenital anomalies compared with women who received albendazole.

Segundo Pedro Alonso, a criação do CISM foi motivada pelas profundas desigualdades na esperança de vida entre os diferentes países. Há trinta anos, as diferenças ultrapassavam os 30 anos, dependendo do local onde uma pessoa nascesse. “Isso não era aceitável”, destacou. Para os próximos anos, o desafio passa por garantir que os próprios países disponham de capacidade científica para encontrar soluções para os seus problemas prioritários de saúde.

As part of the PROTECT project – Preparing for Optimized Phase III/IV Trials of Group B Streptococcus Maternal Vaccines in Africa – the Manhiça Health Research Centre (CISM) held two workshops focused on the co-creation of key messages. The sessions brought together policymakers, healthcare professionals, community and religious leaders, pregnant women and their family members, as well as communication specialists, with the aim of developing communication messages and tools t

Mais do que formalizar uma parceria institucional, o acordo abre caminho para uma colaboração estratégica que poderá fortalecer a cooperação científica em saúde, num contexto em que a complexidade dos desafios de saúde pública exige respostas cada vez mais integradas, sustentadas por investigação científica de excelência, formação qualificada e cooperação entre instituições.